These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effect of Losartan, a nonpeptide angiotensin II receptor antagonist, on drinking behavior and renal actions of centrally administered renin. Barbella Y; Cierco M; Israel A Proc Soc Exp Biol Med; 1993 Apr; 202(4):401-6. PubMed ID: 8456103 [TBL] [Abstract][Full Text] [Related]
25. Effect of nonpeptide angiotensin AT-1 and AT-2 antagonists on isoproterenol-induced renin release. Rowland NE; Fregly MJ Pharmacol Biochem Behav; 1993 Mar; 44(3):623-6. PubMed ID: 8451266 [TBL] [Abstract][Full Text] [Related]
26. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats. Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925 [TBL] [Abstract][Full Text] [Related]
27. Renin gene and angiotensin II AT1 receptor gene expression in the kidneys of normal and of two-kidney/one-clip rats. Della Bruna R; Bernhard I; Gess B; Schricker K; Kurtz A Pflugers Arch; 1995 Jun; 430(2):265-72. PubMed ID: 7675636 [TBL] [Abstract][Full Text] [Related]
28. HR 720, a novel angiotensin receptor antagonist inhibits the angiotensin II-induced trophic effects, fibronectin release and fibronectin-EIIIA+ expression in rat aortic vascular smooth muscle cells in vitro. Dunn FW; Roux MH; Farhadian F; Sabri K; Ossart C; Samuel JL; Rappaport L; Hamon G J Pharmacol Exp Ther; 1997 Jan; 280(1):447-53. PubMed ID: 8996227 [TBL] [Abstract][Full Text] [Related]
29. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751 [TBL] [Abstract][Full Text] [Related]
30. Stimulation of prolactin secretion from rat pituitary by luteinizing hormone-releasing hormone: evidence against mediation by angiotensin II acting through a (Sar1-Ala8)-angiotensin II-sensitive receptor. Robberecht W; Andries M; Denef C Neuroendocrinology; 1992 Aug; 56(2):185-94. PubMed ID: 1407372 [TBL] [Abstract][Full Text] [Related]
31. Roles of renal and vascular renin in spontaneous hypertension and switching of the mechanism upon nephrectomy. Lack of hypotensive effects of inhibition of renin, converting enzyme, and angiotensin II receptor blocker after bilateral nephrectomy. Inagami T; Murakami T; Higuchi K; Nakajo S Am J Hypertens; 1991 Jan; 4(1 Pt 2):15S-22S. PubMed ID: 2009142 [TBL] [Abstract][Full Text] [Related]
32. Regulation of aldosterone biosynthesis by adrenal renin is mediated through AT1 receptors in renin transgenic rats. Volpe M; Rubattu S; Gigante B; Ganten D; Porcellini A; Russo R; Romano M; Enea I; Lee MA; Trimarco B Circ Res; 1995 Jul; 77(1):73-9. PubMed ID: 7788884 [TBL] [Abstract][Full Text] [Related]
33. Angiotensin II type 1 receptor: role in renal growth and gene expression during normal development. Tufro-McReddie A; Johns DW; Geary KM; Dagli H; Everett AD; Chevalier RL; Carey RM; Gomez RA Am J Physiol; 1994 Jun; 266(6 Pt 2):F911-8. PubMed ID: 8023970 [TBL] [Abstract][Full Text] [Related]
34. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748 [TBL] [Abstract][Full Text] [Related]
35. Effects of human renin in the vasculature of rats transgenic for human angiotensinogen. Müller DN; Hilgers KF; Bohlender J; Lippoldt A; Wagner J; Fischli W; Ganten D; Mann JF; Luft FC Hypertension; 1995 Aug; 26(2):272-8. PubMed ID: 7635534 [TBL] [Abstract][Full Text] [Related]